Diapulse® Corporation of America is the pioneer and leader in the biophysical therapeutic effects of non-thermal pulsed electromagnetic energy in medicine.
Diapulse® is indicated for the adjunctive use in the palliative treatment of post-operative edema and pain in superficial soft tissues in acute and chronic wounds.
Diapulse® is Medicare Covered to treat Stage III and IV pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in Hospitals, Nursing Homes, Therapy Clinics and Physician Offices.